Search results
Controlled human infection study paves the way to improving vaccines and therapeutics development
Medical Xpress· 2 days agoThe research is published in The Lancet Microbe journal. People who do not have antibodies against a particular infectious agent are "seronegative" and those who have antibodies are called " ...
EXPLAINER: Boosters key to fight omicron, lot still to learn
AOL· 2 days agoThe new omicron variant took only a few weeks to live up to dire predictions about how hugely...
Risk of uveitis recurrence higher in year after COVID vaccination
Center for Infectious Disease Research and Policy· 5 days agoThe odds of the condition were increased among recipients of all 4 vaccines studied: Pfizer,...
Chinese scientist, first to publish COVID sequence, protests lab lockout
Fox News· 4 days agoThe first scientist to publish the COVID-19 virus sequence in China staged a sit-in protest outside...
Moderna Puts Up Big Quarterly Beat; Could Shares Break Out?
Investor's Business Daily· 2 days agoThe Covid vaccine maker came out of the March quarter with a $3.07 loss per share, reversing from a...
Why Africa is facing an uphill battle to make its own vaccines
Daily Telegraph· 3 days agoA lot of the focus on making domestic products has been on using new technology, like mRNA, which...
We May Be Facing an Epidemic of This Brain Disease
Mercola· 5 days agoAccording to mounting data, one of the more serious side effects of the COVID mRNA jabs appears to be dementia, and worse yet, this previously untransmissible disease may now be “contagious, ...
GSK Beats Q1 Earnings & Sales Estimates, Ups 2024 Guidance
Zacks via Yahoo Finance· 3 days agoGSK's revenues benefit from strong growth across the Specialty Medicines and Vaccines segments. The...
America’s Infectious-Disease Barometer Is Off
The Atlantic· 4 days agoThe ongoing outbreak of H5N1 avian flu virus looks a lot like a public-health problem that the United States should be well prepared for. Although this...
GSK Beats Q1 Earnings & Sales Estimates, Ups 2024 Guidance
Zacks· 3 days agoGSK's revenues benefit from strong growth across the Specialty Medicines and Vaccines segments. The company raises guidance for earnings and sales for the full year.